Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 4Head and Neck Neoplasms 2Virus Diseases 1Tumor Virus Infections 1Recurrence 1Pharyngeal Diseases 1Papillomavirus Infections 1Otorhinolaryngologic Neoplasms 1Otorhinolaryngologic Diseases 1Oropharyngeal Neoplasms 1Neoplasms, Squamous Cell 1Neoplasms, Glandular and Epithelial 1Neoplasms by Site 1Neoplasms by Histologic Type 1Locally Advanced Head and Neck HPV Negative Squamous Cell Cancers 1Laryngeal Diseases 1Hypoxia 1DNA Virus Infections 1Carcinoma, Squamous Cell 1Carcinoma 1

Interventions

Cisplatin 13Cetuximab 10Radiotherapy 7pembrolizumab 4Pemetrexed 4Fluorouracil 4Docetaxel 4Gemcitabine 3durvalumab 2Surveys and Questionnaires 2Radiotherapy, Intensity-Modulated 2Nivolumab 2Narrow Band Imaging 2N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide 2Gefitinib 2Drug Therapy 2Carboplatin 2tremelimumab 1niraparib 1monalizumab 1linrodostat 1dostarlimab 1capmatinib 1X-Rays 1Vitamin B 12 1Tirapazamine 1Tablets 1Sugars 1Radiotherapy, Adjuvant 1Radiosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Laryngeal Diseases × Nimorazole × Clear all
NCT01733823 2017-07-28

DAHANCA 28A: Phase I/II Study on Accelerated, Hyperfractionated Radiotherapy With Concomitant Cisplatin and Nimorazole

Danish Head and Neck Cancer Group

Phase 1/2 Completed
31 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Laryngeal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡